Article

Influence of Interstitial Lung Disease on Systemic Sclerosis Hospitalizations, A National Study (2002-2020)

2024-07-23

Abstract excerpt

<title>Abstract</title> <p>Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that can cause generalized inflammation and is characterized by fibrosis of the skin, organs and vasculopathy. Limited SSc is more common and typically less serious and less frequent diffuse has a higher mortality rate due to end organ damage. One of the most common complications of SSc is interstitial lung disease (IL...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 401ba646-27c0-5c9d-a47f-95703326f45c
DOI: 10.21203/rs.3.rs-4614031/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Influence of Interstitial Lung Disease on Systemic Sclerosis Hospitalizations, A National Study (2002-2020)DOI 10.21203/rs.3.rs-4614031/v1Read

Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosisSemantic proximity Read

Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.Semantic proximity Read

Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016.Semantic proximity Read

Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapy.Semantic proximity Read

Mortality in systemic sclerosis-a single centre study from the UK.Semantic proximity Read

Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.Semantic proximity Read

Mortality and Prognostic Factors for Spontaneous Pneumothorax in Older Adults: A Retrospective StudySemantic proximity Read

Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD).Semantic proximity Read

High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studiesSemantic proximity Read

Safety and Efficacy of Rituximab in Systemic Sclerosis: A Systematic Review and Meta-analysisSemantic proximity Read

Impact of establishing a respiratory high dependency unit for SCAP patients on the therapeutic effect, prognosis, and expenditure: a retrospective case-control studySemantic proximity Read

Supplemental oxygen costs and equipment utilization in a low-income population with ILD or COPDSemantic proximity Read